Next generation personalized cancer therapy

About Viewpoint

Viewpoint Molecular Targeting, LLC develops pharmaceutical drugs for diagnostic imaging and therapy for cancer, with a focus on metastatic melanoma. Our novel image-guided therapies enable a personalized approach to select patients that can benefit most and to optimize treatment planning for our targeted therapies. Our unique “theranostic” agents possess properties for both diagnostic imaging and therapy for cancer, personalizing the selection of patients and optimizing patient care.

Partners & Alliances

Viewpoint is teaming with an experienced world-class team of companies and academic centers to bring its novel product line of theranostic agents to personalized patient care for metastatic melanoma.

News & Awards